Food products produced using genome editing technology could go on sale in Japan by the end of the year despite no specific labelling rules being in place.
Current microbiome analysis methods are lacking high-resolution measurements and are unlikely to yield clinically relevant data in many conditions, but genome guided metagenomic analysis could address these current limitations.